CASE REPORT

A 12-year-old boy without a significant past medical history presented with a parotid mass. The neck magnetic resonance imaging (MRI) revealed a 2.4-cm-sized mass with irregular margins in the deep subcutaneous fat layer of the right cheek (Fig. 1). Several other masses with similar characteristic signal changes as the right cheek mass were identified in the deep fat layer in the right mandibular angle and submandibular area.

A fine needle aspiration was performed on the right cheek mass. The aspirated smear had a necrotic background and showed both syncytial tissue fragments and scattered single cells (Fig. 2). The smear showed tiny necrotic foci. The tumor cells were relatively small (nucleus about 9 µm, cytoplasm about 20 µm in the longest diameter) and had pale cytoplasm and indistinct cell borders. The tumor nuclei were ovoid with small nucleoli and the chromatin was evenly dispersed and hyperchromatic. The nuclear membranes had slight irregularity with occasional grooves. Most single cells had naked nuclei and occasional mitotic figures were identified. Squamous or glandular differentiation was not evident. A right total parotidectomy with neck dissection was performed for tumor removal and pathologic confirmation of the tumor subtype.

Microscopically, it revealed numerous tumor islands forming sheets or nests within the desmoplastic stroma (Fig. 3). The tumor cells had similar cytologic characteristics to those of the aspirated smear (Fig. 3). Metastasis to the cervical lymph nodes as well as perineural and lymphatic invasion was found. As the tumor cells did not demonstrate any differentiation, diverse immunohistochemical stains including pancytokeratin (Leica Microsystem, Novocastra, Newcastle upon Tyne, UK), vimentin (Dako, Carpinteria, CA, USA), p63 (Biogenex, San Ramon, CA, USA), S-100 (Dako), CD34 (Leica Microsystem), synaptophysin (Leica Microsystem), chromogranin A (Leica Microsystem), CD56 (Leica Microsystem), smooth muscle actin (Dako), desmin (Dako), Wilms tumor-1 (Leica Microsystem), and CD99 (Dako) were performed. The tumor cells expressed only pancytokeratin and p63 (Fig. 3).

At first glance, the most possible diagnosis of this case was poorly differentiated squamous cell carcinoma based on the immunohistochemical staining results. However, we hesitated to report squamous cell carcinoma owing to the patient's young age, and lack of smoking history or squamous differentiation on light microscopic examination. Finally, we performed the NUT (1:100, C52B1, Cell Signaling Technology, Danvers, MA, USA) immunostain using tissue section as well as cell block section from the aspirate. The tumor nuclei showed diffuse strong immunoreactivity to NUT and we were able to diagnose NUT midline carcinoma (Figs. 2, 3).

Despite intensive postoperative chemo-radiation therapy, two recurrent events occurred within 1 year after the initial operation. The patient experienced disease progression and expired 2 years after the first presentation.

DISCUSSION

NUT midline carcinoma is a rare and aggressive subset of squamous cell carcinoma, genetically defined by chromosomal translocation involving the NUT gene.1 In about two thirds of NUT midline carcinomas, NUT is fused to BRD4 [t(15;19)] and in the remainder of cases, it is either fused to BRD3 [t(9;15)] or to unknown partner (NUT-variant).4 This cancer affects primarily the mediastinum, head and neck, but it arises in many other organs, such as the urinary bladder, iliac bone, pancreas, parotid gland, and lung.3,4,5 It occurs in people of any ages (range, 0 to 78 years) or gender. NUT midline carcinoma is refractory to conventional chemotherapy and radiotherapy. It has a fatal clinical course with median survival of 6.7 months.6 Two therapeutic agents targeting the BRD4-NUT oncogene (bromodomain inhibitors and histone deacetylase inhibitors) have emerged and are in phase I clinical trials.4 Therefore, an early and proper diagnosis of NUT midline carcinoma would become essential.

Unfortunately, the histopathology of NUT midline carcinomas is not diagnostic. They are composed of sheets or nests of undifferentiated tumor cells with varying degrees of squamous differentiation.4,7 Large areas of coagulative necrosis and extensive desmoplastic stroma may be present.7 Their morphology overlaps with that of many other poorly differentiated malignant neoplasm and NUT midline carcinoma is frequently misdiagnosed as squamous cell carcinoma, poorly differentiated carcinoma, sinonasal undifferentiated carcinoma, Ewing sarcoma, leukemia, thymic carcinoma (if in the thorax), or neuroblastoma.7,8 However, there are a few morphologic features which could suggest NUT midline carcinoma such as relatively monotonous and round tumor cells and foci of abrupt squamous differentiation in about 50% of cases.3,4,7

Bellizzi et al.9 and Zhu et al.10 described the cytologic features of NUT translocated carcinoma. The cytologic characteristics was a highly cellular, predominantly discohesive pattern of relatively small tumor cells with a round nucleus, scant cytoplasm, irregular nuclear contours, variably prominent nucleoli, and identifiable mitotic figures. Overt keratinization, which may be typical in surgical specimens, was not identified, while occasional cells with a denser cytoplasm were noted in one case. The original cytologic diagnoses were "consistent with sinonasal undifferentiated carcinoma" and "consistent with metastatic carcinoma." Distinction of NUT midline carcinoma from other undifferentiated carcinomas without any ancillary tests is nearly impossible in cytology specimens. However, despite the absence of pathognomic cytologic or histologic features, it is critical to know this entity and to consider confirmative tests because NUT midline carcinoma has a very aggressive clinical course and might be managed by other types of chemotherapeutic regimens.

For a confirmative diagnosis of NUT midline carcinoma, karyotyping, fluorescence in situ hybridization (FISH), or NUT mRNA by reverse transcription polymerase chain reaction can be used to detect the NUT gene rearrangement.4 However, these tests are not widely available and have not been commercialized. Recently, both monoclonal8 and polyclonal7 NUT specific antibodies were developed for IHC. Haack et al.8 assessed the accuracy of monoclonal NUT (C52) antibody to detect NUT rearranged carcinoma confirmed by FISH. They demonstrated that NUT IHC had a sensitivity of 87% and a specificity of 100% when diagnosing NUT midline carcinoma among nongerm cell tumors. Generally, germ cells in the testis and oocytes are stained with NUT antibody. Germ cell tumors such as dysgerminoma, seminoma, and embryonal carcinoma were reported to show focal (<5%), weak nuclear staining with C52, presumably due to the normal expression of NUT in tumor cells, whereas NUT midline carcinomas showed diffuse (>50%), speckled nuclear staining.8 Thus, IHC using the NUT specific antibody can be used as an alternative diagnostic test if the tumor cells show diffuse immunoreactivity to the NUT specific antibody.

Almost all NUT midline carcinomas show immunoreactivity to p63,5,7,9 reflecting the squamous nature of this tumor. However, it is very unique in that it is characterized by a single chromosomal translocation like leukemia/lymphoma, in contrast to complex karyotypes and aneuploidy in typical squamous cell carcinomas. In addition, none of the smoking-related squamous cell carcinoma of the head and neck showed NUT immunostaining or gene rearrangement.8 This suggests that NUT midline carcinoma might arise through a different pathogenesis. The NUT oncogene may represent a short-cut to squamous cancer, bypassing multiple processes of environmentally-acquired mutations and genetic instability in conventional squamous cell carcinoma.3,4

In this report, we presented a case of NUT midline carcinoma, which developed in the parotid gland of an adolescent boy. NUT midline carcinoma is a recently described, uncommon disease with a fatal outcome and is underdiagnosed due to nonspecific morphologic features. In cases with poorly differentiated malignancy of the head and neck, it is important to be aware of this entity and to perform NUT immunostaining in a cytology specimen for proper diagnosis and patient management.

REFERENCES

• 1. French CA, Kutok JL, Faquin WC, et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol 2004; 22: 4135-4139. ArticlePubMed
• 2. Kubonishi I, Takehara N, Iwata J, et al. Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma. Cancer Res 1991; 51: 3327-3328. ArticlePubMed
• 3. French CA. The importance of diagnosing NUT midline carcinoma. Head Neck Pathol 2013; 7: 11-16. ArticlePubMedPMC
• 4. French CA. Pathogenesis of NUT midline carcinoma. Annu Rev Pathol 2012; 7: 247-265. ArticlePubMed
• 5. den Bakker MA, Beverloo BH, van den Heuvel-Eibrink MM, et al. NUT midline carcinoma of the parotid gland with mesenchymal differentiation. Am J Surg Pathol 2009; 33: 1253-1258. ArticlePubMed
• 6. Bauer DE, Mitchell CM, Strait KM, et al. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res 2012; 18: 5773-5779. ArticlePubMedPMC
• 7. Stelow EB, Bellizzi AM, Taneja K, et al. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol 2008; 32: 828-834. ArticlePubMed
• 8. Haack H, Johnson LA, Fry CJ, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol 2009; 33: 984-991. ArticlePubMedPMC
• 9. Bellizzi AM, Bruzzi C, French CA, Stelow EB. The cytologic features of NUT midline carcinoma. Cancer 2009; 117: 508-515. ArticlePubMed
• 10. Zhu B, Laskin W, Chen Y, et al. NUT midline carcinoma: a neoplasm with diagnostic challenges in cytology. Cytopathology 2011; 22: 414-417. ArticlePubMed

Fig. 1

Radiologic findings. Neck magnetic resonance imaging reveals an infiltrative mass (arrow) with strong gadolinium enhancement, located in the deep fat layer of the right cheek.

Fig. 2

Cytologic findings. (A) The smear shows many cohesive clusters with single scattered cells. (B) Tumor cell necrosis is found. (C) The tumor cells are relatively small and uniform with irregular ovoid nuclei, small nucleoli, and occasional mitosis. (D) NUT immunohistochemistry (C52) using the aspirated smear slide reveals diffuse nuclear immunoreactivity.

Fig. 3

Histopathologic findings. (A) The tumor is composed of sheets of poorly differentiated cells with desmoplastic stroma. (B, C) The tumor cells have relatively small and irregular ovoid nuclei with small nucleoli. Individual cell necrosis (arrow), frequent mitosis, and tiny necrotic foci (arrowhead) are present. Immunohistochemical stains reveal diffuse nuclear immunoreactivity to p63 (D) and the NUT specific antibody (E).

Figure & Data

References

Citations

Citations to this article as recorded by  

• Exploring cytologic features and potential diagnostic challenges of metastatic NUT carcinoma to the parotid gland: A case report and a comprehensive literature review
  Crystal Y. Li, Salih Salihoglu, Francisco J. Civantos, Jaylou M. Velez Torres
  Diagnostic Cytopathology.2024;[Epub]     CrossRef
• NUT carcinoma of the submandibular gland: A case report
  Simone Rota, Pasquale Quattrone, Giovanni Centonze, Gianpaolo Dagrada, Arianna Ottini, Elena Colombo, Imperia Nuzzolese, Giuseppina Calareso, Marzia Franceschini, Nicola Alessandro Iacovelli, Federica Perrone, Elena Tamborini, Stefano Cavalieri
  Cancer Reports.2023;[Epub]     CrossRef
• NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion
  Min Chen, Sha Zhao, Zuoyu Liang, Weiya Wang, Ping Zhou, Lili Jiang
  Virchows Archiv.2022; 480(4): 887.     CrossRef
• NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics
  Vanessa Moreno, Karan Saluja, Sergio Pina-Oviedo
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Salivary Gland NUT Carcinoma with Prolonged Survival in Children: Case Illustration and Systematic Review of Literature
  Huiying Wang, Vivian L. Weiss, Robert D. Hoffman, Ty Abel, Richard H. Ho, Scott C. Borinstein, Kyle Mannion, Julia A. Bridge, Jennifer Black, Jiancong Liang
  Head and Neck Pathology.2021; 15(1): 236.     CrossRef
• NUT Carcinoma of the Submandibular Gland: A Case at This Uncommon Site with Review of the Literature
  Vanessa Moreno, Christopher A. French, Tianhua Guo, Hui Zhu, Songling Zhang, Darryl Duncan, Ron J. Karni, Angel I. Blanco, Syed H. Jafri, Karan Saluja
  Head and Neck Pathology.2021; 16(3): 881.     CrossRef
• Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review
  Taebum Lee, Junhun Cho, Chung‐Hwan Baek, Young‐Ik Son, Han‐Sin Jeong, Man Ki Chung, Sang Duk Hong, Yong Chan Ahn, Dong Ryul Oh, Jae Myoung Noh, Keunchil Park, Myung‐Ju Ahn, Hyung‐Jin Kim, Yi Kyung Kim, Young Hyeh Ko
  Head & Neck.2020; 42(5): 924.     CrossRef
• HDAC Overexpression in a NUT Midline Carcinoma of the Parotid Gland with Exceptional Survival: A Case Report
  Gonçalo Esteves, Joana Ferreira, Rita Afonso, Carmo Martins, Carlos Zagalo, Ana Félix
  Head and Neck Pathology.2020; 14(4): 1117.     CrossRef
• Lung nuclear protein in testis carcinoma in an elderly Korean woman: A case report with cytohistological analysis
  Hwa Jin Cho, Hyun‐Kyung Lee
  Thoracic Cancer.2020; 11(6): 1724.     CrossRef
• Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter Study
  Minsun Jung, Soyeon Kim, June-Koo Lee, Sun Och Yoon, Heae Surng Park, Soon Won Hong, Weon-Seo Park, Ji Eun Kim, Joon Kim, Bhumsuk Keam, Hyun Jik Kim, Hyoung Jin Kang, Dong-Wan Kim, Kyeong Cheon Jung, Young Tae Kim, Dae Seog Heo, Tae Min Kim, Yoon Kyung Je
  The Oncologist.2019; 24(8): e740.     CrossRef
• NUT Carcinoma of the Salivary Glands
  Abbas Agaimy, Isabel Fonseca, Carmo Martins, Khin Thway, Ryan Barrette, Kevin J. Harrington, Arndt Hartmann, Christopher A. French, Cyril Fisher
  American Journal of Surgical Pathology.2018; 42(7): 877.     CrossRef
• Abrupt Dyskeratotic and Squamoid Cells in Poorly Differentiated Carcinoma: Case Study of Two Thoracic NUT Midline Carcinomas with Cytohistologic Correlation
  Taebum Lee, Sangjoon Choi, Joungho Han, Yoon-La Choi, Kyungjong Lee
  Journal of Pathology and Translational Medicine.2018; 52(5): 349.     CrossRef
• A Case of Nuclear Protein in Testis Midline Carcinoma Arising From the Submandibular Gland Duct in a Pregnant Patient
  Younghoon Cho, Bhum Suk Keam, Kyeong Cheon Jung, Bo Hae Kim
  Journal of Oral and Maxillofacial Surgery.2017; 75(9): 2020.     CrossRef
• Pediatric NUT-midline carcinoma: Therapeutic success employing a sarcoma based multimodal approach
  Simone Storck, Alyssa L. Kennedy, Karen J. Marcus, Lisa Teot, Jennifer Vaughn, Astrid K. Gnekow, Bruno Märkl, Ivo Leuschner, Steven G. DuBois, Christopher A. French, Michael C. Frühwald
  Pediatric Hematology and Oncology.2017; 34(4): 231.     CrossRef
• Two Cases of Nuclear Protein in Testis Midline Carcinomas of Sinonasal Tract
  Minhyung Lee, Yong Seok Kang, Tae-Bin Won, Hyun Jik Kim
  Korean Journal of Otorhinolaryngology-Head and Neck Surgery.2017; 60(12): 673.     CrossRef
• Cytological features of NUT midline carcinoma arising in sino‐nasal tract and parotid gland: Report of two new cases and review of the literature
  Jerzy Klijanienko, Christophe Le Tourneau, José Rodriguez, Martial Caly, Stamatios Theocharis
  Diagnostic Cytopathology.2016; 44(9): 753.     CrossRef
• Cytological Features of a Variant NUT Midline Carcinoma of the Lung Harboring theNSD3-NUTFusion Gene: A Case Report and Literature Review
  Shiho Kuroda, Shioto Suzuki, Akira Kurita, Mari Muraki, Yoichiro Aoshima, Fumihiko Tanioka, Haruhiko Sugimura
  Case Reports in Pathology.2015; 2015: 1.     CrossRef